Filing Flows › Phibro Animal Health (PAHC) › Capital expenditures
Phibro Animal Health (PAHC) capital expenditures by quarter
Phibro Animal Health's capital expenditures were $18.8M in Q1 FY27 (first quarter fiscal 2027), -0.5% from Q4 FY26. Over the last 7 quarters it ranged from $7.7M (Q3 FY25) to $18.9M (Q4 FY26).
| Quarter | Capital expenditures | Q/Q | Y/Y |
|---|---|---|---|
| Q1 FY27 | $18.8M | -0.5% | +36% |
| Q4 FY26 | $18.9M | +23% | +44% |
| Q3 FY26 | $15.3M | +38% | +98% |
| Q2 FY26 | $11.1M | -20% | — |
| Q1 FY26 | $13.8M | +5% | — |
| Q4 FY25 | $13.1M | +70% | — |
| Q3 FY25 | $7.7M | — | — |
Q1 FY27 at a glance
Phibro Animal Health, Q1 FY27: revenue $387M (+6% year over year), operating margin 12.8%, net earnings $29.5M, operating cash flow $26.1M. The chart follows the revenue to costs, profit and cash.
Questions
What is Phibro Animal Health's capital expenditures?
Phibro Animal Health's capital expenditures were $18.8M in Q1 FY27 (first quarter fiscal 2027), -0.5% from Q4 FY26.
How has Phibro Animal Health's capital expenditures changed?
Over the last 7 quarters it ranged from $7.7M (Q3 FY25) to $18.9M (Q4 FY26).